Showing 99,261 - 99,280 results of 103,558 for search '(( 2 step decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.54s Refine Results
  1. 99261

    Data_Sheet_1_Cost-effectiveness of ensartinib, crizotinib, ceritinib, alectinib, brigatinib and lorlatinib in patients with anaplastic lymphoma kinase-positive non-small cell lung... by Xia Luo (169127)

    Published 2022
    “…When compared with lorlatinib and alectinib, ensartinib was associated with a lower QALY and decreased total costs; the ICERs for lorlatinib and alectinib were $934,101/ QALY and $164,888/ QALY, respectively.…”
  2. 99262
  3. 99263
  4. 99264
  5. 99265
  6. 99266
  7. 99267
  8. 99268
  9. 99269
  10. 99270
  11. 99271
  12. 99272
  13. 99273
  14. 99274
  15. 99275
  16. 99276
  17. 99277
  18. 99278
  19. 99279
  20. 99280